MacroGenics
MGNX
#9452
Rank
A$0.18 B
Marketcap
A$2.96
Share price
-1.01%
Change (1 day)
35.34%
Change (1 year)

MacroGenics (MGNX) - Total liabilities

Total liabilities on the balance sheet as of June 2026 : A$0.45 Billion

According to MacroGenics's latest financial reports the company's total liabilities are A$0.45 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

MacroGenics - Total liabilities on balance sheet (from 2012 to 2026)

Total liabilities by year

Year Total liabilities Change
2025-12-31A$0.30 B28.36%
2024-12-31A$0.23 B9.38%
2023-12-31A$0.21 B5.19%
2022-12-31A$0.20 B54.25%
2021-12-31A$0.13 B22.41%
2020-12-31A$0.10 B-7.85%
2019-12-31A$0.11 B-7.7%
2018-12-31A$0.12 B32.51%
2017-12-31A$95.61 M62.12%
2016-12-31A$58.97 M-6.46%
2015-12-31A$63.05 M-1.9%
2014-12-31A$64.27 M22.32%
2013-12-31A$52.54 M-11.91%
2012-12-31A$59.64 M-23.71%
2011-12-31A$78.18 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Pfizer
PFE
A$174.70 B 38,123.22%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
A$162.86 B 35,532.45%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
A$126.83 B 27,649.09%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
A$56.83 B 12,334.22%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
A$132.67 B 28,927.29%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
A$98.75 B 21,506.68%๐Ÿ‡บ๐Ÿ‡ธ USA
Xencor
XNCR
A$0.33 B-26.71%๐Ÿ‡บ๐Ÿ‡ธ USA